T. Fukuyama

A prospective, phase II, open-label study (JO22903) of first-line erlotinib in Japanese patients with epidermal growth factor receptor (EGFR) mutation-positive advanced non-small-cell lung cancer (NSCLC)

Kōichi Goto, Makoto Nishio, Noboru Yamamoto et al. · Lung Cancer · 2013 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan Public Health Center-based Prospective Study (JPHC Study)

Eiko Saito, Manami Inoue, Norie Sawada et al. · Annals of Epidemiology · 2015 · 85 citations

Public Health, Health Sciences, Nutrition +9

Dietary intake of saturated fatty acids and incident stroke and coronary heart disease in Japanese communities: the JPHC Study

Kazumasa Yamagishi, Yasuaki Kokubo, Isao Saito et al. · European Heart Journal · 2013 · 78 citations · Full text

Public Health, Nutrition, Nutritional Sciences +17

Prospective and clinical validation of ALK immunohistochemistry: results from the phase I/II study of alectinib for ALK-positive lung cancer (AF-001JP study)

Kengo Takeuchi, Yosuke Togashi, Yuki Kamihara et al. · Annals of Oncology · 2015 · 58 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Dietary patterns and colorectal cancer risk in middle-aged adults: A large population-based prospective cohort study

Sangah Shin, Eiko Saito, Norie Sawada et al. · Clinical Nutrition · 2017 · 31 citations

Public Health, Nutrition, Nutritional Sciences +17